NYSE$NHC

National HealthCare Corporation · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

NHC reported earnings for Q4 2021, with net income attributable to National HealthCare Corporation being $15,788,000 and adjusted net income being $15,801,000.

National HealthCare Corporation reported an increase in adjusted net income for the quarter ended December 31, 2021, compared to the same period in 2020. The GAAP diluted earnings per share were $1.02, and adjusted diluted earnings per share were $1.02.

  • Net operating revenues and grant income for the year ended December 31, 2021 totaled $1,074,302,000.
  • GAAP net income attributable to NHC for the year ended December 31, 2021 was $138,590,000.
  • GAAP diluted earnings per share were $8.99 for the year ended December 31, 2021.
  • GAAP net income attributable to NHC for the quarter ended December 31, 2021, was $15,788,000.

Headline financials

Total Revenue

$283M

Previous: $260M+9.1%
EPS (adj)

$1.02

Previous: $0.90+13.3%
Capital Expenditures

$13.6M

Previous: $4.16M+227.8%
Free Cash Flow

$1.9M

Previous: $15.2M-87.5%
Net Income

$15.8M

Previous: $27.6M-42.7%
Operating Income

$0.00

Previous: $12.8M-100.0%
Gross Profit

$99.9M

Previous: $95.7M+4.4%
Cash & Equivalents

$108M

Previous: $147M-26.8%
Total Assets

$1.4B

Previous: $1.36B+3.0%
Stock-Based Comp

$715K

Previous: $646K+10.7%

Revenue & EPS history

NHC · Revenue · Quarterly

$283M

Q4 2021+9.1%vs Q4 2020

Revenue by segment

NHC · $260M total across 2 segments · Q1 2023

  • Net patient revenues
    $258M+2.8%
  • Other revenues
    $2.06M-87.5%

Forward guidance

No forward guidance provided in the press release.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+1.8%

Avg return

30 days after

60%

39 / 65 earnings

Positive

+12.2%

Q2 2023

Best reaction

-14.0%

Q4 2009

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+11.8%+12.9%
Q4 2025+2.0%-4.7%-3.7%
Q3 2025+1.1%+3.4%+7.8%
Q1 2025+1.6%-3.1%-3.3%
Q4 2024+0.8%+0.1%-0.2%
Q3 2024+4.5%-0.1%-4.8%
Q2 2024+3.2%+3.7%+6.4%
Q1 2024+0.9%+4.4%+7.4%
Q4 2023+5.8%+7.1%-0.1%
Q3 2023+1.8%+3.9%+14.2%
Q2 2023+12.2%+12.6%+12.5%
Q1 2023+1.9%+5.4%+11.5%
Q4 2022-2.4%-3.9%-8.2%
Q3 2022-3.2%-1.0%-1.3%
Q2 2022+1.1%+1.9%+0.8%
Q1 2022+2.8%+0.8%+1.9%
Q4 2021+0.5%+0.4%+9.6%
Q3 2021+5.9%+1.3%-10.0%
Q2 2021-0.8%-2.4%-5.9%
Q1 2021-1.5%-1.6%+2.4%
Q4 2020+3.7%+10.3%+20.5%
Q3 2020-1.8%+13.0%+2.3%
Q2 2020+5.8%+5.0%-1.2%
Q1 2020-0.0%-5.0%+5.4%
Q4 2019-0.2%-8.4%-16.6%
Q3 2019-0.4%+0.1%+1.1%
Q2 2019-0.6%+0.4%-5.3%
Q1 2019+0.1%+1.4%+2.3%
Q4 2018+1.8%-0.2%-4.2%
Q3 2018-2.3%-3.5%-2.1%
Q2 2018+1.7%+4.4%+5.3%
Q1 2018+3.0%+3.8%+8.3%
Q4 2017-7.1%-2.5%-3.3%
Q3 2017-1.0%+2.9%+0.4%
Q2 2017+0.0%+2.3%-3.8%
Q1 2017-1.1%-1.2%-2.2%
Q4 2016+1.0%+0.8%+0.3%
Q3 2016-2.1%+1.0%+7.6%
Q2 2016+1.9%+2.6%+4.7%
Q1 2016-0.6%
Q4 2015-1.6%
Q3 2015+0.5%
Q2 2015-3.4%
Q1 2015+0.1%
Q4 2014+1.0%
Q3 2014+1.9%
Q2 2014+0.4%
Q1 2014+2.3%
Q4 2013-0.4%
Q3 2013+0.7%
Q2 2013+1.5%
Q1 2013-0.3%
Q4 2012+1.2%
Q3 2012+1.8%
Q2 2012-1.0%
Q1 2011-4.9%
Q1 2012+3.2%
Q4 2011-0.9%
Q3 2010+7.9%
Q3 2011+7.9%
Q4 2009-14.0%
Q4 2010-14.0%
Q2 2010-14.0%
Q2 2011-14.0%
Q1 2010+3.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro